Monitoring of Minimal Residual Disease in Acute Myeloid LeukemiaKERN, Wolfgang; HAFERLACH, Claudia; HAFERLACH, Torsten et al.Cancer. 2008, Vol 112, Num 1, pp 4-16, issn 0008-543X, 13 p.Article

Molecular diagnostics in acute leukemiasBACHER, Ulrike; SCHNITTGER, Susanne; HAFERLACH, Claudia et al.Clinical chemistry and laboratory medicine. 2009, Vol 47, Num 11, pp 1333-1341, issn 1434-6621, 9 p.Article

Clinical Utility of Multiparameter Flow Cytometry in the Diagnosis of 1013 Patients With Suspected Myelodysplastic Syndrome: Correlation to Cytomorphology, Cytogenetics, and Clinical DataKERN, Wolfgang; HAFERLACH, Claudia; SCHNITTGER, Susanne et al.Cancer. 2010, Vol 116, Num 19, pp 4549-4563, issn 0008-543X, 15 p.Article

A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemiaBACHER, Ulrike; HAFERLACH, Torsten; KERN, Wolfgang et al.Haematologica (Roma). 2007, Vol 92, Num 6, pp 744-752, issn 0390-6078, 9 p.Article

Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemiaDICKER, Frank; HAFERLACH, Claudia; KERN, Wolfgang et al.Blood. 2007, Vol 110, Num 4, pp 1308-1316, issn 0006-4971, 9 p.Article

Insight into the molecular pathogenesis of myeloid malignanciesHAFERLACH, Torsten; BACHER, Ulrike; HAFERLACH, Claudia et al.Current opinion in hematology. 2007, Vol 14, Num 2, pp 90-97, issn 1065-6251, 8 p.Article

RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemiaSCHNITTGER, Susanne; BACHER, Ulrike; KERN, Wolfgang et al.British journal of haematology. 2009, Vol 146, Num 6, pp 665-668, issn 0007-1048, 4 p.Article

Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosisFLACH, Johanna; DICKER, Frank; SCHNITTGER, Susanne et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 518-519, issn 0390-6078, 2 p.Article

The Impact of Cytomorphology, Cytogenetics, Molecular Genetics, and Immunophenotyping in a Comprehensive Diagnostic Workup of Myelodysplastic SyndromesBACHER, Ulrike; HAFERLACH, Torsten; KERN, Wolfgang et al.Cancer. 2009, Vol 115, Num 19, pp 4524-4532, issn 0008-543X, 9 p.Article

Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalitiesSCHÄFER, Martin; SCHWENDER, Holger; MERK, Sylvia et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 24, pp 3228-3235, issn 1367-4803, 8 p.Article

Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be betterclassified as early-stage CLLKERN, Wolfgang; BACHER, Ulrike; HAFERLACH, Claudia et al.British journal of haematology. 2012, Vol 157, Num 1, pp 86-96, issn 0007-1048, 11 p.Article

Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cellsBACHER, Ulrike; HAFERLACH, Claudia; ALPERMANN, Tamara et al.Haematologica (Roma). 2011, Vol 96, Num 9, pp 1284-1292, issn 0390-6078, 9 p.Article

Prognostic relevance of FLT3-TED mutations in AML : the combination matters-an analysis of 3082 patients. CommentaryLEVIS, Mark; BACHER, Ulrike; HAFERLACH, Claudia et al.Blood. 2008, Vol 111, Num 5, issn 0006-4971, 2503-2504, 2527-2537 [13 p.]Article

Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B-CLL) and its genetic characterizationKERN, Wolfgang; BACHER, Ulrike; SCHNITTGER, Susanne et al.British journal of haematology. 2014, Vol 164, Num 4, pp 565-569, issn 0007-1048, 5 p.Article

IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 statusSCHNITTGER, Susanne; HAFERLACH, Claudia; ULKE, Madlen et al.Blood. 2010, Vol 116, Num 25, pp 5486-5496, issn 0006-4971, 11 p.Article

EZH2 mutations and their association with PICALM-MLLT10 positive acute leukaemiaGROSSMANN, Vera; BACHER, Ulrike; HAFERLACH, Claudia et al.British journal of haematology. 2012, Vol 157, Num 3, pp 387-390, issn 0007-1048, 4 p.Article

TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining alleleBACKER, Ulrike; WEISSMANN, Sandra; KOHLMANN, Alexander et al.British journal of haematology. 2012, Vol 156, Num 1, pp 67-75, issn 0007-1048, 9 p.Article

CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemiaHAFERLACH, Claudia; BACHER, Ulrike; KOHLMANN, Alexander et al.Haematologica (Roma). 2011, Vol 96, Num 6, pp 829-836, issn 0390-6078, 8 p.Article

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosisBROSEUS, Julien; FLORENSA, Lourdes; MARIA RAYA, José et al.Haematologica (Roma). 2012, Vol 97, Num 7, pp 1036-1041, issn 0390-6078, 6 p.Article

Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 casesSCHNITTGER, Susanne; BACHER, Ulrike; KERN, Wolfgang et al.Haematologica (Roma). 2012, Vol 97, Num 12, pp 1890-1894, issn 0390-6078, 5 p.Article

Response of ETV6-FLT3―positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3WALZ, Christoph; ERBEN, Philipp; HOFMANN, Wolf-Karsten et al.Blood. 2011, Vol 118, Num 8, pp 2239-2242, issn 0006-4971, 4 p.Article

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeGROSSMANN, Vera; TIACCI, Enrico; TRIFONOV, Vladimir et al.Blood. 2011, Vol 118, Num 23, pp 6153-6163, issn 0006-4971, 11 p.Article

SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterationsNOWAK, Daniel; OGAWA, Seishi; CHANG, Mi-Sook et al.Blood. 2010, Vol 115, Num 5, pp 1049-1053, issn 0006-4971, 5 p.Article

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IVHEHLMANN, Rüdiger; MÜLLER, Martin C; SCHNITTGER, Susanne et al.Journal of clinical oncology. 2014, Vol 32, Num 5, pp 415-423, issn 0732-183X, 9 p.Article

Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotypeHAFERLACH, Claudia; ALPERMANN, Tamara; SCHNITTGER, Susanne et al.Blood. 2012, Vol 119, Num 9, pp 2122-2125, issn 0006-4971, 4 p.Article